LPA基因变异与主动脉瓣狭窄的关联:基于电子健康记录的大规模研究
结果显示两个变异均与主动脉瓣狭窄显著相关,携带两个风险等位基因者风险增加2倍以上,且年龄可能修饰该关联。
要点
- LPA变异rs10455872和rs3798220与主动脉瓣狭窄风险显著相关。
- 携带两个风险等位基因者主动脉瓣狭窄风险增加2倍以上。
- rs10455872风险等位基因在55-64岁人群中关联最强,随年龄增长减弱。
核心结论
- 两个LPA变异与主动脉瓣狭窄的关联达到全基因组显著性水平。
- 携带两个风险等位基因的个体发生主动脉瓣狭窄的风险增加2倍或以上。
- 年龄可能修饰LPA变异与主动脉瓣狭窄的关联。
研究设计与样本
- 研究对象来自Genetic Epidemiology Research on Aging队列,为Kaiser Permanente Northern California医疗系统成员。
主要发现
- rs10455872每风险等位基因的比值比为1.34(95% CI 1.23-1.47;P=1.7×10^-10)。
- rs3798220每风险等位基因的比值比为1.31(95% CI 1.09-1.58;P=3.6×10^-3)。
- rs10455872纯合子比值比为2.05(95% CI 1.37-3.07;P=5.3×10^-4)。
临床怎么用
- LPA变异检测可能有助于识别主动脉瓣狭窄高风险个体。
- 对于携带两个LPA风险等位基因者,可考虑加强主动脉瓣狭窄的监测。
- 年龄(尤其55-64岁)可能影响LPA变异与主动脉瓣狭窄的关联强度。
局限性
- 研究仅纳入欧洲血统个体,结果外推至其他种族需谨慎。
- 主动脉瓣狭窄诊断基于电子健康记录编码,可能存在错分偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Elevated lipoprotein(a) levels are a risk factor for aortic stenosis (AS). However, a large-scale replication of associations between LPA variants and AS, their interactions with risk factors, and the effect of multiple risk alleles is not well established. OBJECTIVE: To replicate the association between LPA variants with AS and identify subgroups who are at higher risk of developing AS. DESIGN, SETTING, AND PARTICIPANTS: This case-control study of AS included 44 703 individuals (3469 cases) 55 years or older who were enrolled in the Genetic Epidemiology Research on Aging cohort and who were members of the Kaiser Permanente Northern California health care delivery system. The study leveraged the linkage of administrative health data, electronic medical records, genotypes, and self-reported questionnaire data. The 3469 AS cases were diagnosed between January 1996 and December 2015. Individuals with congential valvular heart disease were excluded. EXPOSURES: Two single-nucleotide polymorphisms in the LPA locus, rs10455872 and rs3798220, that are known to associate with circulating plasma lipoprotein(a) levels and an LPA risk score. MAIN OUTCOMES AND MEASURES: Aortic stenosis or aortic valve replacement. RESULTS: The 44 703 participants were of European ancestry,of whom 22 019 (49.3%) were men. The mean (SD) age for the control group was 69.3 (8.3) years and the mean (SD) age for AS cases was 74.6 (8.5) years. Both LPA variants were associated with AS, with a per risk allele odds ratio of 1.34 (95% CI, 1.23-1.47; P = 1.7 × 10-10) for rs10455872 and 1.31 (95% CI, 1.09-1.58; P = 3.6 × 10-3) for rs3798220 after adjusting for age, age2, and sex. The results remained significant after adjusting for risk factors. The estimates were similar for an LPA risk score. Individuals with 2 risk alleles had a 2-fold or greater odds of AS compared with individuals with no risk alleles (for rs10455872, homozygous odds ratio, 2.05; 95% CI, 1.37-3.07; P = 5.3 × 10-4; for rs3798220, homozygous odds ratio, 3.74; 95% CI, 1.03-13.62; P = .05; and for compound heterygotes, odds ratio, 2.00; 95% CI, 1.17-3.44; P = .01). For rs10455872, the odds ratio for AS was greatest in individuals aged 55 to 64 years and declined with age (interaction P = .03). Each rs10455872 risk allele was also associated with AS that was diagnosed 0.71 years earlier (95% CI, -1.42 to 0; P = .05). CONCLUSIONS AND RELEVANCE: We provide a large-scale confirmation of the association between 2 LPA variants and AS, reaching genome-wide significance. In addition, individuals with 2 risk alleles have 2-fold or greater odds of developing AS. Age may modify these associations and identify subgroups who are at greater risk of developing AS.
引用
- Chen HY, Dufresne L, Burr H, et al. Association of LPA Variants With Aortic Stenosis: A Large-Scale Study Using Diagnostic and Procedural Codes From Electronic Health Records. JAMA Cardiol. 2018. PMID: 29128868. doi:10.1001/jamacardio.2017.4266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。